This company has been marked as potentially delisted and may not be actively trading. NASDAQ:TLC Taiwan Liposome (TLC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Taiwan Liposome Stock (NASDAQ:TLC) 30 days 90 days 365 days Advanced Chart Get Taiwan Liposome alerts:Sign Up Key Stats Today's Range$7.00▼$7.0950-Day Range$6.76▼$7.6352-Week Range$4.07▼$7.70Volume12,421 shsAverage Volume133,095 shsMarket Capitalization$294.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. Read More Receive TLC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Taiwan Liposome and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TLC Stock News HeadlinesThe Wyatt Sicks Retain Tag Team Championship At WWE SummerSlam 2025 In Wild TLC MatchAugust 4, 2025 | msn.comWWE HOFer Bully Ray Has Two Words For SummerSlam 2025 TLC Match Stars: Good LuckAugust 4, 2025 | msn.comWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.August 28 at 2:00 AM | SmartAsset (Ad)Wyatt Sicks Pull Down WWE Tag Titles In Crowded TLC Match At SummerSlam 2025 Night 2August 4, 2025 | msn.comUnbelievable TLC Title Match Set for SummerSlam 2025July 26, 2025 | msn.comT-Boz Explains How TLC Bought Back The Rights To Their Name Along With The Amount They Paid For Each LetterJuly 19, 2025 | msn.comTLC Spent $3M To Reclaim Group Name Ownership From PebblesJuly 19, 2025 | msn.comSpinoff of TLC’s hit show 90 Day Fiance features ShreveporterJuly 17, 2025 | msn.comSee More Headlines TLC Stock Analysis - Frequently Asked Questions How were Taiwan Liposome's earnings last quarter? Taiwan Liposome Company, Ltd. (NASDAQ:TLC) announced its quarterly earnings results on Wednesday, October, 28th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.13) by $0.06. The business had revenue of $2.28 million for the quarter, compared to analysts' expectations of $0.38 million. Taiwan Liposome had a negative trailing twelve-month return on equity of 120.45% and a negative net margin of 299.27%. When did Taiwan Liposome IPO? Taiwan Liposome (TLC) raised $29 million in an IPO on the week of November 19th 2018. The company issued 5,000,000 shares at $5.80 per share. Cantor acted as the underwriter for the IPO and CLSA, H.C. Wainwright, Janney Montgomery Scott and Laidlaw & Company (UK) Ltd. were co-managers. What other stocks do shareholders of Taiwan Liposome own? Based on aggregate information from My MarketBeat watchlists, some other companies that Taiwan Liposome investors own include Avino Silver & Gold Mines (ASM), Trevena (TRVN), Bionano Genomics (BNGO), Pfizer (PFE), Wells Fargo & Company (WFC), Aadi Bioscience (AADI) and BioLineRx (BLRX). Company Calendar Last Earnings10/28/2020Today8/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:TLC CIK1722890 Webwww.tlcbio.com Phone886226557377FaxN/AEmployees2,020Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$35.02 million Net Margins-299.27% Pretax Margin-306.10% Return on Equity-120.45% Return on Assets-55.11% Debt Debt-to-Equity Ratio0.67 Current Ratio3.01 Quick Ratio3.01 Sales & Book Value Annual Sales$3.63 million Price / Sales81.14 Cash FlowN/A Price / Cash FlowN/A Book Value$0.83 per share Price / Book8.43Miscellaneous Outstanding Shares42,077,000Free FloatN/AMarket Cap$294.54 million OptionableNot Optionable Beta0.99 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:TLC) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taiwan Liposome Company, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taiwan Liposome With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access